Trastuzumab and pertuzumab-based versus other therapy as second-line therapy in HER2-positive metastatic breast cancer: A retrospective study from single center Meeting Abstract


Authors: Fontes Santos De Teive Argolo, D.; Smyth, L. M.; Iyengar, N. M.; Patil, S.; Norton, L.; Baselga, J.; Hudis, C. A.; Dang, C. T.
Abstract Title: Trastuzumab and pertuzumab-based versus other therapy as second-line therapy in HER2-positive metastatic breast cancer: A retrospective study from single center
Meeting Title: 51st Annual Meeting of the American Society of Clinical Oncology (ASCO)
Journal Title: Journal of Clinical Oncology
Volume: 33
Issue: 15 Suppl.
Meeting Dates: 2015 May 29-Jun 2
Meeting Location: Chicago, IL
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2015-05-20
Language: English
ACCESSION: WOS:000358036901408
PROVIDER: wos
DOI: 10.1200/jco.2015.33.15_suppl.616
Notes: Meeting Abstract: 616 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Sujata Patil
    511 Patil
  2. Clifford Hudis
    905 Hudis
  3. Larry Norton
    758 Norton
  4. Chau Dang
    272 Dang
  5. Neil Mukund Iyengar
    150 Iyengar
  6. Jose T Baselga
    484 Baselga
  7. Lillian   Smyth
    42 Smyth
Related MSK Work